(EXX7) iShares Nikkei 225 (DE) - Ratings and Ratios
Japanese Stocks, Equity Funds, Index Tracker, Large Cap Stocks
Description: EXX7 iShares Nikkei 225 (DE)
The iShares Nikkei225 UCITS ETF (DE) is a Japan Large-Cap Blend Equity ETF listed on XETRA with the ticker symbol EXX7. It tracks the Morningstar Japan TME NR JPY index, providing investors with exposure to the Japanese equity market.
With Assets Under Management (AUM) of approximately €28.25 billion, this ETF is a significant player in the Japan Large-Cap Blend Equity category. The funds size indicates a high level of liquidity, making it an attractive option for investors seeking to gain exposure to the Japanese market.
From a performance perspective, the ETFs price movement can be analyzed using various Key Performance Indicators (KPIs). The 52-week high and low prices are €24.81 and €19.69, respectively, indicating a significant price range over the past year. The Average True Range (ATR) is 0.13, or 0.57% of the current price, suggesting relatively low volatility.
To further evaluate the ETFs performance, investors can examine its tracking error, expense ratio, and dividend yield. A low tracking error would indicate that the ETF is effectively replicating the performance of the underlying index. The expense ratio, which represents the funds operating costs, is an essential consideration for investors seeking to minimize costs. Additionally, the dividend yield can provide insight into the ETFs income-generating potential.
Investors can also consider the ETFs sector allocation, market capitalization, and other fundamental characteristics to gain a deeper understanding of its investment profile. For instance, the Nikkei 225 index is known for its heavy weighting in stocks such as Toyota, Sony, and Honda, which are prominent players in the Japanese economy.
EXX7 ETF Overview
| Market Cap in USD | 32,952m |
| Category | Japan Large-Cap Blend Equity |
| IPO / Inception | 2006-07-05 |
EXX7 ETF Ratings
| Growth Rating | 30.5 |
| Fundamental | 45.0% |
| Dividend Rating | 37.7 |
| Rel. Strength | -17.6 |
| Analysts | - |
| Fair Price Momentum | 22.76 EUR |
| Fair Price DCF | - |
EXX7 Dividends
| Dividend Yield 12m | 1.07% |
| Yield on Cost 5y | 1.50% |
| Annual Growth 5y | 0.91% |
| Payout Consistency | 91.2% |
| Payout Ratio | % |
EXX7 Growth Ratios
| Growth Correlation 3m | 54.8% |
| Growth Correlation 12m | -22% |
| Growth Correlation 5y | 58.3% |
| CAGR 5y | 7.47% |
| CAGR/Max DD 5y | 0.34 |
| Sharpe Ratio 12m | -0.21 |
| Alpha | -10.01 |
| Beta | 0.914 |
| Volatility | 15.35% |
| Current Volume | 12.4k |
| Average Volume 20d | 3.5k |
| Stop Loss | 23.7 (-3.3%) |
As of August 10, 2025, the stock is trading at EUR 24.51 with a total of 12,420 shares traded.
Over the past week, the price has changed by +4.79%, over one month by +5.52%, over three months by +7.29% and over the past year by +12.18%.
No, based on ValueRay´s Fundamental Analyses, iShares Nikkei 225 (DE) (XETRA:EXX7) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.00 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXX7 is around 22.76 EUR . This means that EXX7 is currently overvalued and has a potential downside of -7.14%.
iShares Nikkei 225 (DE) has no consensus analysts rating.
According to our own proprietary Forecast Model, EXX7 iShares Nikkei 225 (DE) will be worth about 25.5 in August 2026. The stock is currently trading at 24.51. This means that the stock has a potential upside of +4.04%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.5 | 4% |
ValueRay Score 45.00
| 1. Piotroski 0.0pt = -5.0 |
EXX7 Fundamental Data Overview
Market Cap EUR = 28.25b (28.25b EUR * 1.0 EUR.EUR)
[93m CCE Cash And Equivalents = unknown
[39m[93m Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
[39m Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
[93m Long Term Debt = unknown (none)
[39m[93m Short Term Debt = unknown (none)
[39m[93m Debt = unknown
[39m[93m Net Debt = unknown
[39m Enterprise Value = 28.25b EUR (28.25b + (null Debt) - (null CCE))
[93m Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
[39m[93m FCF Yield = none (FCF TTM 0.0 / Enterprise Value 28.25b)
[39m[93m FCF Margin = unknown (Revenue TTM is 0)
[39m[93m Net Margin = unknown
[39m[93m Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
[39m[93m Tobins Q-Ratio = unknown (Enterprise Value 28.25b / Book Value Of Equity 0.0)
[39m Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
[93m Taxrate = unknown
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m[93m Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
[39m[93m Debt / Equity = unknown Debt (none)
[39m[93m Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
[39m[93m Debt / FCF = none (Debt none / FCF TTM 0.0)
[39m[93m Total Stockholder Equity = unknown
[39m[93m RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
[39m[93m RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
[39m[93m RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
[39m[93m WACC = unknown (E(28.25b)/V(0.0) * Re(9.38%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
[39m Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
[93m Fair Price DCF = unknown (Cash Flow 0.0)
[39m